🔎 Trials Near Me

Dachaigh › Lymphoma Hodgkin › Texas › Houston

Sgrùdaidhean clionaigeach Lymphoma Hodgkin ann an Houston, TX

Tha 14 sgrùdaidhean airson Lymphoma Hodgkin a’ lorg phàirtichean aig làraichean ann agus timcheall air Houston (taobh a-staigh mu 30 mìle). Fosglaidh sgrùdadh gus faicinn cò as urrainn pàirt a ghabhail agus mar a chuireas tu fios air an sgioba.

Teacsa sgrùdaidh oifigeil (Beurla)

A’ fastadh airson sgrùdadh an seo? Seall e aig mullach na duilleige seo — $99 airson 30 latha →

Constitutive IL7R (C7R) Modified Banked Allogeneic CD30.CAR EBVSTS for CD30-Positive Lymphomas

A’ fastadhÌre 1
  • Houston Methodist Hospital, Houston
  • Texas Children's Hospital, Houston
Aoisean 12 gu 75 · Gach gnè · Air ùrachadh 2 Dàmh 2026 · NCT06176690

CD30 CAR T Cells, Relapsed CD30 Expressing Lymphoma (RELY-30)

A’ fastadhÌre 1
  • Houston Methodist Hospital, Houston
  • Texas Children's Hospital, Houston
Aoisean 12 gu 75 · Gach gnè · Air ùrachadh 2 Dàmh 2026 · NCT02917083

Pharmacokinetic Study of Venetoclax Tablets Crushed and Dissolved Into a Solution

A’ fastadhSgrùdadh amharc
  • Texas Children's Hospital, Houston
Aoisean 0 gu 38 · Gach gnè · Air ùrachadh 1 Dàmh 2026 · NCT06131801

A Phase II Trial of Mosunetuzumab, Polatuzumab, Tafasitamab, and Lenalidomide in Patients With Relapsed B-cell NHL

A’ fastadhÌre 2
  • M D Anderson Cancer Center, Houston
Aoisean 18 agus nas sine · Gach gnè · Air ùrachadh 18 Sult 2026 · NCT05615636

AZD3470 as Monotherapy or in Combination With Anticancer Agent(s) in Participants With Haematologic Malignancies.

A’ fastadhÌre 1/2
  • Research Site, Houston
Aoisean 12 agus nas sine · Gach gnè · Air ùrachadh 14 Sult 2026 · NCT06137144

Phase1 Basket Trial Of CAR.70-Engineered IL15-Transduced With TGFBR2 Knock Out Cord Blood-Derived NK Cells For Relapsed/Refractory Lymphoid Malignancies

A’ fastadhÌre 1
  • The University of Texas M. D. Anderson Cancer Center, Houston
Aoisean 18 gu 75 · Gach gnè · Air ùrachadh 8 Sult 2026 · NCT07444632

Phase II Study Of Nivolumab Plus AVD In Pediatric, Adolescent, And Young Adult Patients With CHL

A’ fastadhÌre 2
  • UT MD Anderson, Houston
Aoisean 2 gu 21 · Gach gnè · Air ùrachadh 31 Lùna 2026 · NCT07551583

Personalized NK Cell Therapy in CBT

A’ fastadhÌre 2
  • M D Anderson Cancer Center, Houston
Aoisean 15 gu 80 · Gach gnè · Air ùrachadh 30 Iuch 2026 · NCT02727803

A Multicenter Access and Distribution Protocol for Unlicensed Cryopreserved Cord Blood Units (CBUs)

A’ fastadhSgrùdadh amharc
  • M.D. Anderson Cancer Center, Houston
  • Texas Children's Hospital - Baylor Medical Center, Houston
Gach aois · Gach gnè · Air ùrachadh 6 Iuch 2026 · NCT01351545

EBV Specific T-Lymphocytes for Treatment of EBV-Positive Lymphoma

A’ fastadhÌre 1
  • Harris Health System - Ben Taub General Hospital/Smith Clinic, Houston
  • Houston Methodist Hospital, Houston
  • Texas Children's Hospital, Houston
  • agus 1 a bharrachd
Gach aois · Gach gnè · Air ùrachadh 25 Ògmh 2026 · NCT04664179

A Phase II Study of the Combination of Azacitidine and Pembrolizumab for Patients Relapsed/Refractory Hodgkin's Lymphoma

A’ fastadhÌre 2Fàilte do shaor-thoilich fhallain
  • MD Anderson Cancer Center, Houston
Aoisean 1 agus nas sine · Gach gnè · Air ùrachadh 18 Cèit 2026 · NCT05355051

Cytotoxic T-Lymphocytes for EBV-positive Lymphoma, GRALE

A’ fastadhÌre 1
  • Harris Health System (includes ben Taub General Hospital and Smith), Houston
  • Houston Methodist Hospital, Houston
  • Texas Children's Hospital, Houston
Gach aois · Gach gnè · Air ùrachadh 2 Màrt 2026 · NCT01555892

Tagraxofusp in Pediatric Patients With Relapsed or Refractory CD123 Expressing Hematologic Malignancies

A’ fastadhÌre 1
  • Texas Children's Hospital/Baylor College of Medicine, Houston
Aoisean 1 gu 21 · Gach gnè · Air ùrachadh 6 Dùbh 2024 · NCT05476770

Sgrùdaidhean Lymphoma Hodgkin ann am bailtean eile

Sgrùdaidhean eile ann an Houston

Bho ClinicalTrials.gov, dàta air a thogail 6 Dàmh 2026. Bidh gach sgrùdadh a’ suidheachadh a chuidi fhèin; bidh an sgioba sgrùdaidh a’ co-dhùnadh cò as urrainn pàirt a ghabhail.